Successful treatment of acute kidney allograft rejection using extracorporeal photopheresis in the context of post‐transplant lymphoproliferative diseases: three successive cases - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Transplant International Year : 2021

Successful treatment of acute kidney allograft rejection using extracorporeal photopheresis in the context of post‐transplant lymphoproliferative diseases: three successive cases

Abstract

We reported 3 kidney transplant patients with PTLD who developed mixed AR following IS treatment minimization. AR episodes were treated with extracorporeal photopheresis (ECP), methylprednisolone and IVIG. In all patients, graft function improved under ECP and stabilized in the long term. These observations suggest that ECP is safe and efficient for treatment of AR in the context of PTLD.
Embargoed file
Embargoed file
Visibility date is undetermined

Dates and versions

inserm-03549859 , version 1 (31-01-2022)

Identifiers

Cite

Jf Augusto, Philippe Gatault, Johnny Sayegh, Anne‐sophie Garnier, Agnès Duveau, et al.. Successful treatment of acute kidney allograft rejection using extracorporeal photopheresis in the context of post‐transplant lymphoproliferative diseases: three successive cases. Transplant International, 2021, 34 (11), pp.2415 - 2417. ⟨10.1111/tri.14006⟩. ⟨inserm-03549859⟩
19 View
15 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More